Follow
Escher, Johanna C
Escher, Johanna C
Unknown affiliation
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents
A Levine, S Koletzko, D Turner, JC Escher, S Cucchiara, L de Ridder, ...
Journal of pediatric gastroenterology and nutrition 58 (6), 795-806, 2014
11762014
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
FM Ruemmele, G Veres, KL Kolho, A Griffiths, A Levine, JC Escher, ...
Journal of Crohn's and Colitis 8 (10), 1179-1207, 2014
11452014
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
G Van Assche, A Dignass, W Reinisch, CJ van der Woude, A Sturm, ...
Journal of Crohn's and Colitis 4 (1), 63-101, 2010
9312010
Coeliac disease
M Mäki, P Collin
The lancet 349 (9067), 1755-1759, 1997
8781997
ESPEN guideline: Clinical nutrition in inflammatory bowel disease
A Forbes, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ...
Clinical Nutrition 36 (2), 321-347, 2017
6932017
European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations
R Caprilli, MA Gassull, JC Escher, G Moser, P Munkholm, A Forbes, ...
Gut 55 (suppl 1), i36-i58, 2006
6342006
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function
DS Shouval, A Biswas, JA Goettel, K McCann, E Conaway, NS Redhu, ...
Immunity 40 (5), 706-719, 2014
5692014
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
JF Dekkers, G Berkers, E Kruisselbrink, A Vonk, HR De Jonge, ...
Science translational medicine 8 (344), 344ra84-344ra84, 2016
5482016
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines
D Turner, A Levine, JC Escher, AM Griffiths, RK Russell, A Dignass, ...
Journal of pediatric gastroenterology and nutrition 55 (3), 340-361, 2012
4632012
The medical management of paediatric Crohn’s disease: an ECCO-ESPGHAN guideline update
PF Van Rheenen, M Aloi, A Assa, J Bronsky, JC Escher, UL Fagerberg, ...
Journal of Crohn's and Colitis 15 (2), 171-194, 2021
4312021
Inflammatory bowel disease in children and adolescents: recommendations for diagnosis‐the Porto criteria
IBD Working Group of the European Society for Paediatric Gastroenterology ...
Journal of Pediatric Gastroenterology and Nutrition 41 (1), 1-7, 2005
376*2005
European evidence-based consensus on the management of ulcerative colitis: special situations
L Biancone, P Michetti, S Travis, JC Escher, G Moser, A Forbes, ...
Journal of Crohn's and Colitis 2 (1), 63-92, 2008
3172008
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
SC Bischoff, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ...
Clinical Nutrition 39 (3), 632-653, 2020
3162020
Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis
J Hyams, L Damaraju, M Blank, J Johanns, C Guzzo, HS Winter, ...
Clinical Gastroenterology and hepatology 10 (4), 391-399. e1, 2012
3012012
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN
D Turner, SPL Travis, AM Griffiths, FM Ruemmele, A Levine, EI Benchimol, ...
Official journal of the American College of Gastroenterology| ACG 106 (4 …, 2011
2492011
European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and …
A Levine, S Koletzko, D Turner, JC Escher, S Cucchiara, L De Ridder, ...
J Pediatr Gastroenterol Nutr 58 (6), 795-806, 2014
2432014
Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease
R Baldassano, CP Braegger, JC Escher, K DeWoody, DF Hendricks, ...
Official journal of the American College of Gastroenterology| ACG 98 (4 …, 2003
2202003
Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease
JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti, S Cucchiara, ...
Gastroenterology 152 (8), 1901-1914. e3, 2017
2132017
Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry
CI De Bie, A Paerregaard, S Kolacek, FM Ruemmele, S Koletzko, ...
Inflammatory bowel diseases 19 (2), 378-385, 2013
2002013
Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric …
E Miele, R Shamir, M Aloi, A Assa, C Braegger, J Bronsky, L De Ridder, ...
Journal of pediatric gastroenterology and nutrition 66 (4), 687-708, 2018
1962018
The system can't perform the operation now. Try again later.
Articles 1–20